Evidence map›Paper›PMID 35233267›Full record

ArticleThe Pan African medical journal2021

Exposure to aflatoxin B

Muhammad Ayaz Mustufa, Zubia Zia, Rabia Ilyas, Rehan Khan, Syed Naim Ul Hasan Naqvi, Firdous Imran Ali

Abstract read
In one paragraph

Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Digestive cancers: mechanisms, therapeutics and management.Signal transduction and targeted therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad Ayaz MustufaBaqai Institute of Pharmaceutical Sciences (BIPS), Baqai Medical University, Karachi-74600, Pakistan.
Zubia ZiaBaqai Institute of Pharmaceutical Sciences (BIPS), Baqai Medical University, Karachi-74600, Pakistan.
Rabia IlyasDepartment of Bio-Chemistry, University of Karachi, Karachi-75270, Pakistan.
Rehan KhanThe Directorate of Anti-Quackery, Sindh Healthcare Commission, Head Office, Karachi-1293, Pakistan.
Syed Naim Ul Hasan NaqviBaqai Institute of Pharmaceutical Sciences (BIPS), Baqai Medical University, Karachi-74600, Pakistan.
Firdous Imran AliDepartment of Chemistry, University of Karachi, Karachi-75270, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionpopulation-based follow-up study has been designed to investigate the contributing factors to high exposure to Aflatoxin B

methodsa semi-structured pre-coded pro forma designed to collect socio-demographic, Pharmacological, biochemical and clinical information from patients and hospital records. Patient´s pre and post polymerase chain reaction (PCR), serum alanine aminotransferase (ALT) levels and other blood parameters were analysed. AFB

resultsAFB

conclusionhigh frequency of AFB

Indexed as

Carcinoma, HepatocellularHepatitis CLiver NeoplasmsAflatoxin B1Follow-Up StudiesHepacivirusHumansPakistanRisk FactorsAflatoxin B1Aflatoxin B1hepatitis C-infected patientshepatocarcinogenichepatotoxicrisk factor

Identifiers

PMID35233267
PMCPMC8831216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.